Biological reagents for immunosuppressants.
Soulillou
J P
JP
Institut de Transplantation et de Recherche en Transplantation, Nantes, France.
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015704:CD4 Antigens / Q000276:immunology; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D018799:Intercellular Adhesion Molecule-1 / Q000276:immunology; D007378:Interleukins / Q000276:immunology; D016169:Lymphocyte Function-Associated Antigen-1 / Q000276:immunology; D008285:Major Histocompatibility Complex; D016853:Muromonab-CD3 / Q000627:therapeutic use*; D015375:Receptors, Interleukin-2 / Q000276:immunology; D014181:Transplantation Immunology
D000911:Antibodies, Monoclonal; D015704:CD4 Antigens; D007166:Immunosuppressive Agents; D007378:Interleukins; D016169:Lymphocyte Function-Associated Antigen-1; D016853:Muromonab-CD3; D015375:Receptors, Interleukin-2; D018799:Intercellular Adhesion Molecule-1